Skip to content

Clinical trials

Leukemia, Myeloid, Acute trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Country / region: Canada Clear all

202 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20032
20043
20053
20066
20077
20088
20097
20108
201112
20127
20137
20149
201516
201617
201714
20189
20196
202012
20218
202211
20233
20249
20257
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed102
Terminated45
Active, not recruiting25
Recruiting16
Unknown status6
Not yet recruiting3
Withdrawn2
No longer available1
Enrolling by invitation1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto15
National Cancer Institute (NCI)13
Celgene9
Novartis Pharmaceuticals9
AbbVie8
Children's Oncology Group8
Astellas Pharma Global Development, Inc.7
Hoffmann-La Roche6
Astex Pharmaceuticals, Inc.5
Daiichi Sankyo5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute202
Leukemia52
Myelodysplastic Syndromes51
Precursor Cell Lymphoblastic Leukemia-Lymphoma35
Recurrence25
Leukemia, Myelomonocytic, Chronic18
Hematologic Neoplasms15
Neoplasms15
Myeloproliferative Disorders14
Leukemia, Myelomonocytic, Acute13

Trials

Showing 76 to 100 of 202. Each trial links to its page on Pharma Observatory.

102 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.